-
New Implantable System for Remodulin for PAH Approved
The U.S. Food and Drug Administration has approved Medtronic’s Implantable System for Remodulin, or ISR, to deliver Remodulin to patients with pulmonary arterial hypertension (PAH).
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.